中国卒中杂志2025，Vol.20Issue(5)：581-594,14.DOI:10.3969/j.issn.1673-5765.2025.05.006
中国卒中预防20年
Two Decades of Stroke Prevention in China
摘要
Abstract
Preventing the occurrence of stroke is the fundamental approach to reducing the burden of stroke disease.As a disease caused by multiple factors,the pathogenesis of stroke involves various risk factors such as lifestyle,genetics,and the environment.Controlling risk factors is the core strategy for reducing the incidence of stroke.Both primary prevention for the non-diseased population and secondary prevention for stroke patients hold significant value in stroke prevention and management.This article systematically reviews the development of stroke prevention in China over the past two decades,focusing on the following three research achievements:first,it summarizes the epidemiological trends and changing characteristics of major stroke risk factors in China based on epidemiological data;second,it examines the implementation of pharmacological interventions in secondary prevention of stroke,with a specific focus on the progress of antiplatelet therapy,and reviews the landmark clinical studies in the field of stroke prevention and their guiding value for clinical practice;finally,it provides a comprehensive review and summary of the evolution of China's stroke screening system and prevention and control strategies.In addition,this article also looks forward to the future development of stroke prevention technology and research directions:emerging technologies such as wearable medical devices and artificial intelligence-assisted decision-making provide new technical means for stroke prevention.However,the application effects and promotional value of these new technologies still need to be further validated by large-scale clinical studies.关键词
卒中/预防/一级预防/二级预防Key words
Stroke/Prevention/Primary prevention/Secondary prevention分类
临床医学引用本文复制引用
张润华,李天琪,翟屹,姜勇,刘改芬..中国卒中预防20年[J].中国卒中杂志,2025,20(5):581-594,14.基金项目
四大慢病重大专项(2023ZD0503600,2023ZD0503605) （2023ZD0503600,2023ZD0503605）
